Klein Buendel, Inc. Proposed here is a mobile web application "mobile web app" for personal computers, smart phones, and tablet computers that will accurately inform parents and adolescent boys about the HPV vaccination and address unique concerns about its safety and effectiveness for boys.
The BoyVac mobile web app will be evaluated for its ability to improve vaccine outcomes in a randomized efficacy trial with parents and adolescent boys aged years.
Részletes leírás The President's Cancer Advisory Board and the Centers for Disease Control have called for renewed efforts in promoting vaccination for Human Papillomavirus HPVincluding vaccination for adolescent boys, because ugill papilloma uptake of this new vaccine remains alarmingly low.
Many parents remain unconvinced of the safety and effectiveness of HPV vaccines, so effective and accessible messaging to improve decision-making on this vaccine is needed.
Parents of adolescent boys also have different concerns about HPV vaccination than for adolescent girls, creating a need for unique health communication interventions to promote vaccine uptake among boys.
Interventions also need to address the unique challenges of minority populations and populations for whom English is not the first language. A novel digital intervention will be produced and evaluated for its ability to improve HPV vaccine outcomes. Specifically, a mobile responsive web application "mobile web app" will be created that performs similar to a mobile app but runs on a variety of computing platforms from personal desktop and laptop computers ugill papilloma the latest smart phones and tablet computers.
Mobile web app content will be targeted to parents and adolescent boys aged years.
The specific aims are to: 1 carefully and systematically develop a mobile web app BoyVac for smart phones, tablet computers, and personal computers that will utilize Diffusion of Innovations principles to provide targeted information concerning HPV vaccine adoption to családi rákos irányelvek males and their parents, particularly minority adolescents and parents; 2 implement a comprehensive and rigorous test of the impact of the BoyVac mobile web ugill papilloma intervention on HPV vaccine adoption outcomes via a randomized efficacy trial BoyVac v.
Parents will be surveyed at baseline, a 3-month follow-up, and a 9-month follow-up and records HPV vaccination adoption for the boys will be obtained from the clinics' medical records at the 9-month follow-up. Analyses will test the hypotheses that 1 more year old boys in the intervention group BoyVac mobile web app will adopt the HPV vaccine than boys in the usual and customary care comparison group and 2 adoption of HPV vaccine ugill papilloma be mediated by improvements in theoretical mediators among parents in the intervention compared to the usual and customary care comparison group.